103 related articles for article (PubMed ID: 27543914)
1. QTc prolongation during peripheral stem cell apheresis in healthy volunteers.
Korur A; Kozanoglu I; Buyukkurt N; Yeral M; Kandemir F; Gereklioglu C; Sariturk C; Asma S; Solmaz S; Boga C; Ozdogu H
J Clin Apher; 2017 Aug; 32(4):240-245. PubMed ID: 27543914
[TBL] [Abstract][Full Text] [Related]
2. QTc prolongation in apheresis platelet donors.
Laspina SJ; Browne MA; McSweeney EN; Lawlor J; Whelan DM; Kinsella AL; Murphy WG
Transfusion; 2002 Jul; 42(7):899-903. PubMed ID: 12375663
[TBL] [Abstract][Full Text] [Related]
3. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.
Ikeda K; Minakawa K; Muroi K; Fujiwara SI; Yamada-Fujiwara M; Fujimori Y; Tanosaki R; Ohto H;
Transfusion; 2016 Nov; 56(11):2839-2847. PubMed ID: 27572290
[TBL] [Abstract][Full Text] [Related]
5. Apheresis on aged patients/donors with complicated backgrounds like ischemic heart disease, arrhythmia, and others.
Yokohama A; Yokote K; Maruhashi T
Transfus Apher Sci; 2018 Oct; 57(5):619-622. PubMed ID: 30262215
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive technical and patient-care optimization in the management of pediatric apheresis for peripheral blood stem cell harvesting.
Ohara Y; Ohto H; Tasaki T; Sano H; Mochizuki K; Akaihata M; Kobayashi S; Waragai T; Ito M; Hosoya M; Nollet KE; Ikeda K; Ogawa C; Kanno T; Shikama Y; Kikuta A
Transfus Apher Sci; 2016 Dec; 55(3):338-343. PubMed ID: 27765663
[TBL] [Abstract][Full Text] [Related]
7. Assessment of corrected QT interval in sickle-cell disease patients who undergo erythroapheresis.
Boga C; Kozanoglu I; Yeral M; Bakar C
Transfus Med; 2007 Dec; 17(6):466-72. PubMed ID: 18067651
[TBL] [Abstract][Full Text] [Related]
8. The corrected QT interval before and after heart transplantation.
Moore JP; Alejos JC; Perens G; Wong S; Shannon KM
Am J Cardiol; 2009 Aug; 104(4):596-601. PubMed ID: 19660618
[TBL] [Abstract][Full Text] [Related]
9. A global assessment of hemostatic function of healthy allogeneic stem cell donors undergoing apheresis by rotational thromboelastometry.
Cilek N; Ugurel E; Eren OC; Yalcin O; Akay OM
Ther Apher Dial; 2024 Aug; 28(4):657-663. PubMed ID: 38462734
[TBL] [Abstract][Full Text] [Related]
10. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
Strauss RG
J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity.
Hegde V; Setia R; Soni S; Handoo A; Sharma SK; Chaudhary D; Kapoor M
Transfus Apher Sci; 2016 Jun; 54(3):373-6. PubMed ID: 26915952
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the CD34
Guo ZP; Wang T; Xu LP; Zhang XH; Wang Y; Huang XJ; Chang YJ
Transfus Apher Sci; 2016 Dec; 55(3):311-317. PubMed ID: 27665155
[TBL] [Abstract][Full Text] [Related]
13. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
Gordon SV; Nivison-Smith I; Szer J; Chapman JR
Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection.
Lee SN; Sohn JY; Kong JH; Eom HS; Lee H; Kong SY
Ann Lab Med; 2017 Jul; 37(4):327-330. PubMed ID: 28445013
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience.
Ozen M; Gunduz M; Topcuoglu P; Toprak SK; Dalva K; Gurman G; Ilhan O
J Clin Apher; 2017 Feb; 32(1):16-20. PubMed ID: 26958783
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two apheresis systems for autologous stem cell collections in pediatric oncology patients.
Even-Or E; Eden-Walker A; Di Mola M; McDougall E; Schechter T; Ali M; Svajger G; Gassas A; Licht C; Krueger J
Transfusion; 2017 Jan; 57(1):122-130. PubMed ID: 27696435
[TBL] [Abstract][Full Text] [Related]
18. Donors' health state the year after peripheral haematopoietic progenitor cell collection: A prospective follow-up study in related and unrelated donors compared to first-time platelet donors.
Bank I; Wiersum-Osselton JC; Van Walraven SM; Netelenbos T; Fechter M; Marijt-van der Kreek T; Bär BM; Van der Bom JG; Brand A
J Clin Apher; 2016 Dec; 31(6):523-528. PubMed ID: 26812941
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion.
Nicolini FE; Wattel E; Michallet AS; Bourgeot JP; Tremisi JP; Hequet O; Michallet M
Exp Hematol; 2004 Nov; 32(11):1033-9. PubMed ID: 15539080
[TBL] [Abstract][Full Text] [Related]
20. Risks of leukapheresis and how to manage them-A non-systematic review.
Stenzinger M; Bonig H
Transfus Apher Sci; 2018 Oct; 57(5):628-634. PubMed ID: 30287071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
